Bank of Montreal
AIMT

Bank of Montreal’s Aimmune Therapeutics AIMT Stock Holding History

Bank of Montreal’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,184
Closed -$109K – 5243
2020
Q3 		$109K Sell
3,184
-1,037
-25% -$22.1K ﹤0.01% 3033
2020
Q2 		$65K Buy
4,221
+3,721
+744% +$63.2K ﹤0.01% 3303
2020
Q1 		$7K Sell
500
-6,322
-93% -$162K ﹤0.01% 3623
2019
Q4 		$228K Buy
6,822
+1,925
+39% +$53.8K ﹤0.01% 3094
2019
Q3 		$103K Buy
4,897
+534
+12% +$10.9K ﹤0.01% 3279
2019
Q2 		$90K Buy
4,363
+3,363
+336% +$69.2K ﹤0.01% 3401
2019
Q1 		$22K Sell
1,000
-516
-34% -$12.1K ﹤0.01% 3652
2018
Q4 		$37K Buy
1,516
+491
+48% +$12.7K ﹤0.01% 3414
2018
Q3 		$28K Sell
1,025
-709
-41% -$20.1K ﹤0.01% 3596
2018
Q2 		$46K Buy
1,734
+334
+24% +$10.2K ﹤0.01% 3446
2018
Q1 		$45K Hold
1,400
– – ﹤0.01% 3281
2017
Q4 		$53K Buy
+1,400
New +$45.2K ﹤0.01% 3251

Bank of Montreal's AIMT Position: Q4 2020 in Review

Bank of Montreal sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 3,184 shares — an estimated $109K sold.

Bank of Montreal first reported a position in AIMT in Q4 2017 and held it in 12 quarters. The position peaked at $228K in Q4 2019. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Bank of Montreal reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Bank of Montreal sold 3,184 Aimmune Therapeutics shares in Q4 2020, an estimated $109K.
  • Bank of Montreal first reported a position in Aimmune Therapeutics in Q4 2017 and held it in 12 quarters.
  • Bank of Montreal's Aimmune Therapeutics position peaked at $228K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.